Autoplaque vs cvi42 Auto Imaging

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 80/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by APQ Health (formerly Cedars-Sinai Medical Center: AIM)
VS
by Circle Cardiovascular Imaging Inc.

AI Verdict

Autoplaque is a specialized AI tool focused on quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. cvi42 Auto Imaging offers a broader cardiovascular imaging analysis platform, which includes similar AI-powered plaque assessment from CT, alongside extensive MR and other CT functionalities. Therefore, while cvi42 Auto Imaging encompasses a wider range of features and modalities, both tools directly compete in the specific area of coronary plaque analysis from CT.

Choose Autoplaque if…

Choose Autoplaque if your primary need is highly specialized, AI-powered quantitative analysis of coronary plaques and luminal stenoses exclusively from CT angiography images. This workstation-based tool is ideal for clinicians focused on precise heart attack risk prediction and guiding treatment decisions based solely on coronary CTA findings.

View Autoplaque →

Choose cvi42 Auto Imaging if…

Choose cvi42 Auto Imaging if you require a comprehensive, multi-modality solution for analyzing both cardiovascular MR and CT images across a wider range of applications. This tool is best suited for practices needing to streamline clinical workflows with AI-enabled automated contouring, detailed cardiac function analysis (MR), vascular assessment, and integrated smart reporting for a holistic view of cardiovascular health.

View cvi42 Auto Imaging →

For a physician evaluating AI tools for cardiovascular imaging, Autoplaque and cvi42 Auto Imaging offer distinct strengths. Autoplaque, developed by Cedars-Sinai AIM, is an FDA-cleared workstation-based software specifically designed for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. Its core utility lies in aiding heart attack risk prediction and treatment guidance through automated vessel, plaque, and lumen segmentation, which clinicians can review and edit. This tool is best suited for cardiologists or radiologists primarily focused on detailed coronary plaque assessment from CTAs.

In contrast, cvi42 Auto Imaging by Circle Cardiovascular Imaging provides a more comprehensive, multi-modality approach, analyzing both cardiovascular MR and CT images. While it also offers plaque quantification, its feature set extends to cardiac MR analysis (function, flow, tissue characterization, strain) and vascular CT analysis, alongside robust 3D visualization and simplified reporting. The key practical difference is Autoplaque’s specialized focus on coronary CTA plaque analysis versus cvi42 Auto Imaging’s broader, multi-modality cardiovascular imaging capabilities. Physicians whose practice demands extensive analysis across various cardiovascular imaging modalities, including MR, would find cvi42 Auto Imaging more versatile, while those with a primary need for in-depth, quantitative coronary CTA plaque assessment may prefer Autoplaque’s specialized functionality.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Autoplaque cvi42 Auto Imaging
Pricing Unknown Starts at $5000 per license
Deployment Workstation-based post-processing application, runs on Windows or Mac OS. On-premise (standalone workstation or client/server)
FDA Status Cleared AI-estimated Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

cvi42 Auto Imaging

cvi42 Auto Imaging (Tool B) emphasizes an 'unmatched user experience' with 'simplified and smart reporting with infographics and CAD-RADS classification,' indicating a strong focus on intuitive interpretation and streamlined workflows. While Autoplaque (Tool A) offers reviewable and editable segmentation, cvi42's broader approach to user-friendly reporting and multi-modality support suggests a more refined and comprehensive usability design for daily clinical practice.

Clinical Value

cvi42 Auto Imaging

cvi42 Auto Imaging (Tool B) offers a broader clinical value by providing comprehensive analysis across both MR and CT images, including cardiac function, flow, tissue characterization, strain, and vascular CT, in addition to plaque assessment. Autoplaque (Tool A) is more narrowly focused on quantitative analysis of coronary plaques and luminal stenoses from CT angiography, despite its strong clinical validation. The multi-modality and extensive analytical capabilities of cvi42 provide a more holistic view for cardiovascular diagnosis and treatment planning.

Pricing & Value

cvi42 Auto Imaging

Both tools have undisclosed pricing. However, cvi42 Auto Imaging (Tool B) provides more insight into its pricing model, mentioning a flexible 'Elevate pricing structure' that scales with usage and offers modular licensing. This modularity and volume-aligned pricing, combined with its ability to help sites retain reimbursement for AI-enabled plaque analysis, suggests a more adaptable and potentially higher value proposition for various clinical settings.

Enterprise Readiness

cvi42 Auto Imaging

cvi42 Auto Imaging (Tool B) demonstrates superior enterprise readiness with explicit support for networked environments, cloud compatibility, and simplified integrations with PACS/VNA, EMR, DICOM, and HL7. Its widespread adoption in over 1,700 hospitals globally further highlights its proven ability to integrate into diverse healthcare IT infrastructures. Autoplaque (Tool A), described primarily as workstation-based, appears less geared for broad enterprise deployment.

Innovation

cvi42 Auto Imaging

While both tools leverage AI for automated analysis, cvi42 Auto Imaging (Tool B) demonstrates broader innovation through its multi-modality and vendor-neutral platform, advanced reporting with CAD-RADS classification, and continuous expansion into new areas like vascular CT analysis and CT Strain. Its focus on a unified platform that integrates diverse AI-driven workflows across multiple imaging types showcases a more comprehensive and evolving innovative strategy.

Support & Docs

cvi42 Auto Imaging

cvi42 Auto Imaging (Tool B) clearly excels in this dimension, explicitly detailing various support channels including live chat, email, phone, and comprehensive documentation such as help guides, webinars, and on-site training. The company also highlights its global team, commitment to customer service, and industry-leading satisfaction scores. Autoplaque (Tool A) has no publicly available information on its support structure or documentation beyond a user manual.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Autoplaque cvi42 Auto Imaging
Company Cedars-Sinai Medical Center: AIM (exclusive worldwide license to APQ Health Inc.) Circle Cardiovascular Imaging
Description AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. AI-powered software for comprehensive analysis of cardiovascular MR and CT images, aiding in precise diagnosis, plaque quantification, and streamlined clinical workflows.
Key Features (Plaque Analysis) AI-powered quantitative analysis of atherosclerotic plaque; Detection and characterization of coronary artery plaque; Measurement of luminal stenoses; Automated vessel, plaque, and lumen segmentation (reviewable and editable by clinician); Measurement of vessel diameter and area. AI-enabled automated contouring and segmentation; Cardiac CT analysis (Plaque Assessment, Calcium Scoring, Coronary Arteries); Quantitative analysis (plaque volume, mass, function, signal intensity); Per-lesion and per-vessel plaque analysis supports precise risk stratification through detailed assessment of calcified, non-calcified, and low-attenuation plaques; Remodeling index assessment; Editable plaque segmentation.
Additional Imaging Modalities/Analysis Analysis of coronary anatomy and pathology from CT Angiographic images. Cardiac MR analysis (Function, Flow, Tissue Characterization, Strain); Cardiac CT analysis (Calcium Scoring, Coronary Arteries); Vascular CT analysis (diagnosis, planning, surveillance); Multi-modality support (MR, CT) and vendor-neutral compatibility.
Reporting The Autoplaque patient report. Simplified and smart reporting with infographics and CAD-RADS classification; Smart reporting with infographics and CAD-RADS classification; Enhanced coronary reporting; Plaque Education Report for referring physicians; Standard Integrated Report; Customizable template builder; Export PDF, text, DICOM secondary capture and DICOM encapsulated pdf; HL7 integration.
Data Processing Workstation-based post-processing application. Local processing for complete data security; all image data and derived results are managed locally, whether on a hospital workstation or through a customer-managed server installation. No data is ever transmitted outside the institution. The AI model is 'frozen' and does not learn from customer data processed at the site.

Videos

Demos, reviews, and walkthroughs featuring Autoplaque and cvi42 Auto Imaging.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Autoplaque is designed for quantitative analysis of coronary plaques and luminal stenoses specifically from CT angiography images. In contrast, cvi42 Auto Imaging offers multi-modality support, analyzing both cardiac MR and CT images, including vascular CT analysis.
Autoplaque focuses on the quantitative analysis of coronary plaques and luminal stenoses for heart attack risk prediction and treatment guidance. cvi42 Auto Imaging provides a broader range of cardiac analysis, including cardiac MR analysis for function, flow, tissue characterization, and strain, in addition to cardiac CT analysis for calcium scoring and coronary arteries.
Autoplaque offers AI-powered quantitative analysis of atherosclerotic plaque, including detection, characterization, and measurement of luminal stenoses, with automated vessel, plaque, and lumen segmentation that is reviewable and editable. cvi42 Auto Imaging includes AI-enabled automated contouring and segmentation, and quantitative analysis of plaque as part of its comprehensive cardiac CT analysis capabilities.
Autoplaque supports review of heart and coronary vessels in Multiplanar Reformatting (MPR), curved MPR, and straightened MPR views, and allows clinicians to review and edit automated segmentations. cvi42 Auto Imaging features 3D visualization and multiplanar reconstruction (MPR), alongside simplified and smart reporting that incorporates infographics and CAD-RADS classification.
AI Tool Finder
AI-powered search. Results may not be comprehensive.